Hey, you're listening to Unlimited Hangout on your host Whitney Webb.

On September 12th, Joe Biden announced an executive order on advancing biotechnology

and biomeanufacturing innovation for a sustainable, safe, and secure American bio-economy.

Among other things, this executive order stated that, quote,

we need to develop genetic engineering technologies and techniques to be able to

write circuitry for cells and predictably program biology in the same way in

which we write software and program computers.

Unlock the power of biological data, including through computing tools and

artificial intelligence, and advance the science of scale-up production while

reducing the obstacles for commercialization so that innovative technologies and

products can reach markets faster. In other words, this policy calls for less

regulation and testing for quote, unquote, innovative healthcare products based

on new, unproven technologies, particularly gene editing and gene therapy,

and supercharging the effort to make AI central to the American healthcare

system. But there's actually a lot more going on in this executive order. So

this executive order perhaps unsurprisingly got little play in mainstream media

and only slightly more an independent media where many of those who did cover

it claimed it would usher in an age of transhumanist technologies. It's such

alarm warranted and what is this executive order likely to mean for the

average American? And what exactly is the bio-economy who are the major players in

it and who is it meant to benefit? Joining me discuss this in more today is

Derek Browse. Derek is a journalist activist and speaker who writes for the

...